1206dkM

Saxo Equity World Cup: Novo Nordisk to eclipse Ecopetrol for victory?

Picture of Peter Garnry
Peter Garnry

Chief Investment Strategist

For a complete list of five-year price charts for all stocks in Saxo's 2018 Equity World Cup, click here.

In our Saxo Equity World Cup introduction we explained the rules and structure of the game. In addition we made a prediction for the whole tournament based on which stock we believe has the best odds. We based our prediction on the momentum factor alone.

As Ecopetrol had the highest momentum, we went with a prediction that Colombia would win the Saxo Equity World Cup. But what is the result if we compare the companies in our global equity factor model? Of the 32 companies, only 16 are part of our model. Interestingly enough 14 out 16 companies have a positive score which means that they score above average in our global equity universe consisting of ~1,700 stocks. 

Shares
Source: Saxo Bank

The best company representing a country in our Saxo Equity World Cup is Novo Nordisk with a total score of 0.72, which is such a high score that Novo Nordisk is among the top 10 most attractive stocks in the world according to our model. Novo Nordisk’s high score is driven by the highest quality score of +3, indicating that the company’s return on capital is the best among all the ~1,700 companies.

In addition, Novo Nordisk scores high on the leverage factor (negative net debt and thus zero interest rate sensitivity) and the reversal factor, indicating significant underperformance in the past month. The reversal factor is based on the fact that the stocks that decline the most in the short term are also the ones to subsequently rise the most relative to other stocks.

As the chart below shows, Novo Nordisk has not regained its footing since the declines seen in February as investors doubt the earnings power in the US segment given persistent pricing pressure on insulin. Recent rumours are circulating that Novo Nordisk is considering cutting 3,000 jobs to remain competitive in the US market which would be the ultimate sign that management has lowered their long-term outlook on the US market. However, for the long-term investor, the Novo Nordisk investment case remain intact as diabetes is likely to grow as wealth grows and Western living standards emerge in developing countries.

Novo Nordisk
Novo Nordisk (weekly, source: Saxo Bank)

Quarterly Outlook

01 /

  • Upending the global order at blinding speed

    Quarterly Outlook

    Upending the global order at blinding speed

    John J. Hardy

    Global Head of Macro Strategy

    We are witnessing a once-in-a-lifetime shredding of the global order. As the new order takes shape, ...
  • Equity outlook: The high cost of global fragmentation for US portfolios

    Quarterly Outlook

    Equity outlook: The high cost of global fragmentation for US portfolios

    Charu Chanana

    Chief Investment Strategist

  • Asset allocation outlook: From Magnificent 7 to Magnificent 2,645—diversification matters, now more than ever

    Quarterly Outlook

    Asset allocation outlook: From Magnificent 7 to Magnificent 2,645—diversification matters, now more than ever

    Jacob Falkencrone

    Global Head of Investment Strategy

  • Commodity Outlook: Commodities rally despite global uncertainty

    Quarterly Outlook

    Commodity Outlook: Commodities rally despite global uncertainty

    Ole Hansen

    Head of Commodity Strategy

  • Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    Quarterly Outlook

    Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    John J. Hardy

    Global Head of Macro Strategy

  • Equity Outlook: The ride just got rougher

    Quarterly Outlook

    Equity Outlook: The ride just got rougher

    Charu Chanana

    Chief Investment Strategist

  • China Outlook: The choice between retaliation or de-escalation

    Quarterly Outlook

    China Outlook: The choice between retaliation or de-escalation

    Charu Chanana

    Chief Investment Strategist

  • Commodity Outlook: A bumpy road ahead calls for diversification

    Quarterly Outlook

    Commodity Outlook: A bumpy road ahead calls for diversification

    Ole Hansen

    Head of Commodity Strategy

  • FX outlook: Tariffs drive USD strength, until...?

    Quarterly Outlook

    FX outlook: Tariffs drive USD strength, until...?

    John J. Hardy

    Global Head of Macro Strategy

  • Fixed Income Outlook: Bonds Hit Reset. A New Equilibrium Emerges

    Quarterly Outlook

    Fixed Income Outlook: Bonds Hit Reset. A New Equilibrium Emerges

    Althea Spinozzi

    Head of Fixed Income Strategy

Content disclaimer

None of the information provided on this website constitutes an offer, solicitation, or endorsement to buy or sell any financial instrument, nor is it financial, investment, or trading advice. Saxo Bank A/S and its entities within the Saxo Bank Group provide execution-only services, with all trades and investments based on self-directed decisions. Analysis, research, and educational content is for informational purposes only and should not be considered advice nor a recommendation.

Saxo’s content may reflect the personal views of the author, which are subject to change without notice. Mentions of specific financial products are for illustrative purposes only and may serve to clarify financial literacy topics. Content classified as investment research is marketing material and does not meet legal requirements for independent research.

Before making any investment decisions, you should assess your own financial situation, needs, and objectives, and consider seeking independent professional advice. Saxo does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

Please refer to our full disclaimer and notification on non-independent investment research for more details.

Saxo Bank A/S (Headquarters)
Philip Heymans Alle 15
2900 Hellerup
Denmark

Contact Saxo

Select region

International
International

All trading and investing comes with risk, including but not limited to the potential to lose your entire invested amount.

Information on our international website (as selected from the globe drop-down) can be accessed worldwide and relates to Saxo Bank A/S as the parent company of the Saxo Bank Group. Any mention of the Saxo Bank Group refers to the overall organisation, including subsidiaries and branches under Saxo Bank A/S. Client agreements are made with the relevant Saxo entity based on your country of residence and are governed by the applicable laws of that entity's jurisdiction.

Apple and the Apple logo are trademarks of Apple Inc., registered in the US and other countries. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC.